We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





Laboratory Experts Show How They Are Leading the Way on Global Trends

By LabMedica International staff writers
Posted on 27 Jul 2023

As the healthcare sector and technology continue to progress, various initiatives are emerging worldwide to meet the needs of the dynamic landscape. More...

At the "Emerging Trends in Laboratory Medicine: Excellence from the Global Community" session at AACC 2023, moderated by ADLM President Shannon Haymond, Ph.D., three global lab experts shared their knowledge and insights on several trending topics: pandemic readiness, environmental sustainability, and machine learning.

Heungsup Sung from the University of Ulsan College of Medicine (Seoul, Republic of Korea) began the session by discussing necessary measures to prepare for future outbreaks of novel or variant infectious diseases. He highlighted how the cooperation and preparedness between the private and public sectors in Korea during the MERS outbreak in 2015 played a critical role in forming response strategies and guidelines for other infectious diseases. This preparedness laid the groundwork for Korea's rapid response at the onset of the COVID-19 pandemic and aided in reducing mortality rates.

Next, Katherine Hayden, president of the Association for Clinical Biochemistry and Laboratory Medicine (ACB, London, UK), focused on the role of appropriate test utilization in efforts to achieve environmental sustainability. While many laboratorians are aware of the negative impact of poor test utilization on patient outcomes and healthcare costs, they may fail to realize that improper test utilization can also harm the environment. Hayden pointed out that labs contribute 2% of single-use plastics worldwide and generate massive carbon emissions. She outlined various opportunities across all stages of the testing process for labs to enhance utilization and cut down on waste, while sharing strategies to reform lab practices and support sustainability.

In the final segment of the session, ADLM Past President Stephen Master from the Children's Hospital of Philadelphia (Philadelphia, PA, USA) offered advice on employing machine learning in the clinical laboratory. Given the sheer volume of data produced by clinical labs, artificial intelligence and machine learning hold substantial promise for deriving valuable insights that could revolutionize laboratory medicine. However, it's crucial that laboratorians familiarize themselves with best practices for implementing these systems as machine learning tools become increasingly accessible. Master provided several useful resources that lab professionals can refer to for machine learning applications, including a new guidance document developed and published by an IFCC working group.

In order to remain at the forefront of innovation, the laboratory community must adopt new initiatives and be prepared to adapt to evolving situations. The wide-ranging and insightful experiences shared by the session's speakers on pandemic readiness, test utilization and sustainability, and machine learning applications, was well encapsulated by Sung: “The collective knowledge gained from past experiences should serve as a foundation for building a resilient healthcare system capable of effectively addressing future challenges.”

Related Links:
University of Ulsan College of Medicine
ACB
Children's Hospital of Philadelphia


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Automated Urinalysis Solution
UN-9000
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The researchers Manel Pérez Pons y Carlos Rodriguez Muñoz at the IRBLleida laboratory (Photo courtesy of IRBLleida)

New Blood RNA Markers Help Advance Precision Medicine for Respiratory Patients

Risk stratification in hospitalized respiratory disease, particularly among older adults with COVID-19, remains challenging despite rich clinical datasets. Blood-based non-coding RNA biomarkers are promising,... Read more

Microbiology

view channel
Image: The “broth” used to monitor red blood cell depletion in whole blood spiked with one colony-forming-unit of E. coli bacteria, each incubated at different orbital shaking speeds—left to right: 0 RPM, 65 RPM, 120 RPM and 200 RPM—after four hours of incubation. This culturing raises a bacteria-rich, plasma-like layer of bacteria to the top of the vials, while clusters of stuck blood cells known as a Rouleaux formation sink to the bottom. (Image Credit: Pak Kin Wong)

New Diagnostic Workflow Identifies Bloodstream Pathogens and Antibiotic Response in Hours

Sepsis is a life-threatening complication of infection that affects more than 1.5 million patients annually in the United States and contributes to roughly one in three in-hospital deaths.... Read more

Pathology

view channel
Image: Researchers evaluated AI models that quantify tumor-infiltrating lymphocytes (TIL) on routine breast tissue slides, where higher TIL levels reflect stronger antitumor response and improved breast cancer outcomes (Image Credit: Shutterstock)

AI Matches Pathologists in Predicting Breast Cancer Prognosis from Immune Cells

Breast cancer is the most common cancer in Australian women, with more than 20,000 cases each year. Prognosis can be informed by counting tumor-infiltrating lymphocytes (TILs) on routine pathology slides,... Read more

Industry

view channel
Image: RaDaR ST uses a tumor-informed approach that identifies up to 48 patient-specific variants through whole-exome sequencing and tracks those variants in plasma to detect circulating tumor DNA (ctDNA) at very low variant allele fractions (VAFs) (Photo courtesy of Neogenomics)

Tumor-Informed MRD Assay Gains Medicare Coverage for Immunotherapy Monitoring

NeoGenomics’ RaDaR ST molecular residual disease (MRD) assay has received expanded coverage from the Centers for Medicare & Medicaid Services’ Molecular Diagnostic Services Program (MolDX) for monitoring... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.